Literature DB >> 17516042

[Progressive muscle atrophy. A rarely diagnosed variant of amyotrophic lateral sclerosis].

T Meyer1, C Münch, F K H van Landeghem, N Borisow, J Dullinger, P Linke.   

Abstract

Progressive muscle atrophy (PMA) is a degenerative disease of the lower motor neuron. The course of the illness and the fatal prognosis correspond to those of amyotrophic lateral sclerosis (ALS). Neuropathologic and genetic findings support categorizing PMA within the spectrum of ALS, even though no clinical sign of a disorder of the upper motor neuron is demonstrable. The diagnosis of PMA is based on advanced extremity pareses and atrophies with a high progression rate. Respiratory insufficiency is determinative of the prognosis. Absent or late affection of bulbar functions is characteristic of the disease. Intraneuronal bunina bodies and ubiquitine-positive inclusions, which are established morphologic characteristics of ALS, are found post mortem. The treatment options of riluzol medication, respiratory therapy, and nutrition are analogous to those for typical ALS.

Entities:  

Mesh:

Year:  2007        PMID: 17516042     DOI: 10.1007/s00115-007-2288-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  9 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives.

Authors:  P M Andersen; G D Borasio; R Dengler; O Hardiman; K Kollewe; P N Leigh; P-F Pradat; V Silani; B Tomik
Journal:  Eur J Neurol       Date:  2005-12       Impact factor: 6.089

3.  Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity.

Authors:  P N Leigh; H Whitwell; O Garofalo; J Buller; M Swash; J E Martin; J M Gallo; R O Weller; B H Anderton
Journal:  Brain       Date:  1991-04       Impact factor: 13.501

4.  Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients.

Authors:  P M Andersen; L Forsgren; M Binzer; P Nilsson; V Ala-Hurula; M L Keränen; L Bergmark; A Saarinen; T Haltia; I Tarvainen; E Kinnunen; B Udd; S L Marklund
Journal:  Brain       Date:  1996-08       Impact factor: 13.501

5.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

6.  A survival analysis of 155 cases of progressive muscular atrophy.

Authors:  A Chiò; F Brignolio; M Leone; P Mortara; M G Rosso; A Tribolo; D Schiffer
Journal:  Acta Neurol Scand       Date:  1985-10       Impact factor: 3.209

7.  Discontinuation of mechanical ventilation in patients with amyotrophic lateral sclerosis.

Authors:  G D Borasio; R Voltz
Journal:  J Neurol       Date:  1998-11       Impact factor: 4.849

Review 8.  Sporadic lower motor neuron disease with adult onset: classification of subtypes.

Authors:  R M van den Berg-Vos; J Visser; H Franssen; M de Visser; J M B V de Jong; S Kalmijn; J H J Wokke; L H van den Berg
Journal:  Brain       Date:  2003-05       Impact factor: 13.501

Review 9.  The spectrum of lower motor neuron syndromes.

Authors:  R M Van Den Berg-Vos; L H Van Den Berg; J Visser; M de Visser; H Franssen; J H J Wokke
Journal:  J Neurol       Date:  2003-11       Impact factor: 4.849

  9 in total
  3 in total

1.  [Provision of assistive devices in amyotrophic lateral sclerosis. Analysis of 3 years case management in an internet-based supply network].

Authors:  A Funke; T Grehl; J Großkreutz; C Münch; B Walter; D Kettemann; C Karnapp; N Gajewski; R Meyer; A Maier; K M Gruhn; T Prell; K Kollewe; S Abdulla; X Kobeleva; S Körner; S Petri; T Meyer
Journal:  Nervenarzt       Date:  2015-08       Impact factor: 1.214

2.  Clinical features and differential diagnosis of flail arm syndrome.

Authors:  Annemarie Hübers; Viviane Hildebrandt; Susanne Petri; Katja Kollewe; Andreas Hermann; Alexander Storch; Frank Hanisch; Stephan Zierz; Angela Rosenbohm; Albert C Ludolph; Johannes Dorst
Journal:  J Neurol       Date:  2015-12-24       Impact factor: 4.849

3.  Study of 962 patients indicates progressive muscular atrophy is a form of ALS.

Authors:  W-K Kim; X Liu; J Sandner; M Pasmantier; J Andrews; L P Rowland; H Mitsumoto
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.